欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/1948/001
药品名称Panzyga
活性成分
    • IMMUNGLOBULIN 100.0 mg/ml
剂型Intravenous infusion
上市许可持有人Octapharma GmbH Elisabeth-Selbert-Str. 11 40764 Langenfeld Germany
参考成员国 - 产品名称Germany (DE)
Panzyga
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Panzyga 100 mg/ml solution pour perfusion
    • Netherlands (NL)
      Panzyga 100 mg/ml oplossing voor infusie
    • Luxembourg (LU)
    • Iceland (IS)
      Panzyga 100 mg/ml Innrennslislyf, lausn
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Panzyga 100 mg/ml Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Panzyga
    • Finland (FI)
    • Latvia (LV)
      Panzyga 100 mg/ml šķīdums infūzijām
    • Lithuania (LT)
      Panzyga 100 mg/ml infuzinis tirpalas
    • Estonia (EE)
      PANZYGA
    • Hungary (HU)
      PANZYGA 100 mg/ml oldatos infúzió
    • Bulgaria (BG)
    • Czechia (CZ)
      Panzyga®
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
      Panzyga
    • Croatia (HR)
许可日期2016/02/04
最近更新日期2024/02/09
药物ATC编码
    • J06BA02 immunoglobulins, normal human, for intravascular adm.
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Biological: Blood Product
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase